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Estensen  et  al. (7)  found  that  certain  agents,  e.g., 
carbamylcholine, which may raise the intracellular 
concentration  of  3',5'-guanosine  monophosphate 
(cyclic GMP),  stimulated polymorphonuclear leu- 
kocyte  (PMN)  chemotaxis,  while  Goetzl  et  al. 
(10)  showed  that  ascorbic  acid  enhanced  move- 
ment of monocytes and of PMN.  In this paper we 
show that  ascorbic acid and carbamylcholine,  like 
serotonin  (12),  can  cause  accumulation  of cyclic 
GMP  in  human  monocytes and  that  all stimulate 
leukotaxis  of these  cells.  Cholinergic stimulation 
increases  cyclic  GMP  in  several  tissues  (IlL 
Serotonin  elevates cyclic GMP  in  the uterus  (I I) 
and  human  umbilical  artery  (6)  as  well  as  in 
monocytes, but no effects of ascorbic acid on cyclic 
GM P in leukocytes have been previously recorded. 
MATERIALS  AND  METHODS 
Leukocyte fractions were prepared by dextran sedimen- 
tation (12) (PMN) or Ficoll-Hypaque separation (Ficoll, 
Pharmacia  Fine Chemicals Inc.,  Piscataway,  N. J.) (3) 
(mononuclear cells) from normal human blood as previ- 
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by activation of complement in fresh human serum with 
endotoxin (Escherichia  coli 0127:B8  lipopolysaccharide 
B, Difco Laboratories, Detroit, Mich.) (5).  Mononuclear 
cell chemotaxis was assayed as described by Snyderman 
et  al.  (13),  using  a  5-#m  Nucleopore  filter  (Wallabs, 
Inc., San Rafael, Calif.), In this assay, chemotaxis is ex- 
pressed as the mean number of cells per high power field 
collected  on  the  lower  surface  of  the  filters.  PMN 
chemotaxis,  measured  using  5tCr  (Amersham/Searle 
Corp.,  Arlington  Heights,  lll.)-Iabeled  PMN  and  a 
modified  Boyden  chamber  with  two  5-#m  micropore 
filters (Millipore Corp.,  Bedford, Mass.), is reported as 
corrected counts per minute lower filter (8).  In both the 
mononuclear  cell  and  PMN  chemotaxis  assays,  cell 
suspensions with or without additions (e.g., serotonin or 
ascorbic acid) were added to one side of the chamber, and 
buffer, with or without activated serum, to the other.  In 
some experiments, the effects of serotonin, ascorbic acid, 
or carbamylcholine on spontaneous (random) migration 
were evaluated using the same chemotactic chambers hut 
substituting  Hanks'  buffer as  the  stimulus  (2,  9).  For 
both PMN and mononuclear cell migration studies, four 
replicate  chambers  were  used  for  each  experimental 
condition. None of the agents tested, when added to the 
attractant  side alone, exhibited chemotactic activity for 
mononuclear  cells  or  PMN.  The  means  of  different 
experiments were compared, using the one-tailed paired 
Student's t-test. 
For measurement of cyclic GMP content, samples of 
cells (2  ml,  1  9  x  101 cells) were distributed to plastic 
vials  and  incubated  for  10  min  at  37~  with  shaking. 
Additions in  a  volume of 0.4  ml (of Krebs-Ringer-Tris 
medium unless otherwise stated) were then made. After 
incubation  as  indicated,  a  2.2-ml  sample  of cells  plus 
medium  from  each  vial  was  added  to  1.0  ml  of  10% 
perchloric  acid  and  homogenized  with  a  Brinkmann 
Polytron  (Brinkmann  Instruments,  Inc.,  Westbury,  N. 
Y.) (4,000  rpm, 45  s). [all]cyclic GMP (<1  pmol, 4.47 
Ci/mmol,  New  England  Nuclear,  Boston,  Mass.)  was 
added, and samples were purified and assayed for cyclic 
GMP  as previously described (12).  None of the agents 
tested, when purified as experimental samples, had any 
effect on  the  cyclic GMP  assay.  All  incubations  were 
carried out in duplicate. 
RESULTS  AND  DISCUSSION 
In  the  mononuclear  cell  chemotaxis  assay,  accu- 
mulation  of cells on the lower surface of the filter 
was relatively slow for the first 30-45  min, and  no 
effect  of serotonin  was  observed.  The  rate  of ac- 
cumulation  of mononuclear cells increased sharply 
after 45  rain,  and  the  increase  was  greater  in  the 
presence  of  10 #M  serotonin  than  in  its  absence. 
As shown  in Table  !,  10 #M  serotonin, which did 
not  significantly affect  random  migration,  caused 
a  marked  increase in  the number of mononuclear 
cells  accumulated  on  the  lower  surface  of the  fil- 
TABLE  1 
Effects of Serotonin  on Mononuclear  Cell Migration 
Random migration (0.05 ml buffer)  Chemotaxis (0.05 ml activated serum) 
10uM 
Exp. no.  No serotonin  serotonin  A  No serotonin  10 #M serotonin  A 
cells~high power field  cells/high power [~eM 
1  4•  1  20•  +16 
2  3•  5•  +2 
3  10•  7•  1  3 
4  4•  1  9•  I  +5  26•  38•  +12 
5*  12•  11  •  -I  54•  72•  +18 
6  49 •  4  69 •  5  +20 
7  10•  69•  10  +59 
8*  48 •  4  110 :e  19  +62 
9*  25•  1  38~8  +13 
10  73 +  8  94 a:  16  +21 
11  66 •  8  107 :~ 8  +41 
Mean  7  11  +4  44  75  +31 
SE  1.8  2.6  4  7  9.5  7.2 
Data are presented as mean •  SE of quadruplicate samples. Assays were carried out for 90 min with or without 10 #M 
serotonin present in the cell suspension. 
* In these experiments, the effect of 50 #M  serotonin on chemotaxis was  -  14  •  3.7 mononuclear cells/high power 
field (mean  •  SE). 
BRIEF NOTES  4~1 ters in 90 min when the chemotactic stimulus was 
present (P  <  0.0025).  In one of these experiments, 
5  ~tM  serotonin  increased  by 63%  the  number of 
mononuclear  cells  accumulated.  With  50  #M 
serotonin,  however,  no  augmentation  of  the 
chemotactic response was demonstrable (Table 1). 
Carbamyleholine, an agent previously  reported to 
enhance  PMN  chemotaxis  (7),  augmented  the 
chemotdctic  response  of  mononuclear  cells  as 
well  (P  <  0.025,  Table  II).  We  also  confirmed 
the  reports of Goetzl et  al.  that ascorbic acid  en- 
hanced  the  chemotactic  responsiveness  of mono- 
nuclear cells,  but because of the small  number of 
experiments  and  the  variability  in  magnitude  of 
the  responses,  the  difference  between  the 
ascorbate-treated cells and control was significant 
only  at  the  10%  level.  Bradykinin  (22  ~M)  and 
histamine  (10  or  100  ~zM)  did  not  enhance 
chemotaxis. 
In  the  sxCr  radioassay  for  PMN  chemotaxis, 
the rate of accumulation of cells in the lower filter 
was low for 60-90 min and then increased sharply. 
As  shown  in Table  1II,  in  a  3-h  assay period,  10 
uM  serotonin  significantly  increased  the  chemo- 
TABLE  I I 
Effect of Serotonin,  Carbamylcholine,  and 
Ascorbic Acid on Mononuclear 
Cell Chemotaxis 
Agent added  Chemotaxis 
cells~high power field 
None  59 •  7 
Serotonin, 10#M  76 •  9 
Carbamylcholine, I nM  75 •  7 
Ascorbic acid, 5 mM  85 •  18 
Data are presented as mean •  SE of three experiments in 
which all agents were simultaneously tested. 
TABLE Ill 
Effect of Serotonin  on PMN Chemotaxis 
Acti- 
vated  No. of 
serum  exp 
Chemotaxis 
No serotonin  A due to serotonin 
corrected counts per minute 
0.05 ml  4  2,244•  +1,210• 
0.1  ml  4  3,213  •  770  +781 •  165' 
Assays were carried out for 3 h with or without  10 t~M 
serotonin present in the cell suspension.  Data  are  pre- 
sented  as  mean  •  SE  for  the  indicated  number  of 
experiments. 
* P<0.01. 
tactic  response  of these  cells.  The  effect  of sero- 
tonin when 0.05 ml of activated serum was used as 
the attractant tended to  be greater than when 0.1 
ml  of serum  was  present.  In the  presence of 0.05 
ml  of  activated  serum,  5  mM  ascorbic  acid  also 
enhanced  PMN  chemotaxis. 
in earlier studies (12), serotonin induced a  rapid 
increase in the cyclic GMP  content of monocytes, 
which  reached  a  maximum  within  2  rnin  and 
remained  elevated  for  at  least  30  rain.  After 
incubation  for  90  rain  with  10 #M  serotonin,  the 
cyclic  GMP  content  of  mononuclear  cells  was 
about twice the basal level. In 5-rain incubations, 5 
mM  ascorbic  acid  dramatically  increased  cyclic 
GMP  to  levels  much  higher  than  those  observed 
with  serotonin,  whereas  the  effect  of  10  nM 
carbamylcholine  was  smaller  than  that  of  sero- 
tonin  (Table  IV).  Even  50  #M  ascorbic  acid 
increased the cyclic GMP  content of mononuclear 
cells  about  200%  (Fig.  1).  No  effects  of  any  of 
these agents on  the cyclic GMP  content  of PMN 
were  demonstrable.  The  rise  in  cyclic  GMP  in- 
duced  by  ascorbic acid  (or by serotonin [12]) was 
accompanied  by  no  change  in  adenosine  3',5'- 
monophosphate.  We have shown that the increase 
in cyclic GMP  produced  by serotonin in mononu- 
clear cell fractions is attributable to the response of 
the adherent monocytes in these preparations (12), 
and  in similar experiments  it was  found to  be the 
monocytes,  rather than  the  nonadherent  lympho- 
cytes, that accumulated cyclic GM P in response to 
ascorbic acid (data  not shown). 
Thus,  in  the  human  monocytes,  ascorbic  acid, 
carbamylcholine, and serotonin, in concentrations 
that enhanced chemotactic responsiveness, caused 
TABLE IV 
Effects of Serotonin,  Carbamylcholine,  and 
Ascorbic Acid on Cyclic GMP in Mononuclear 
Cells 
No. of  A Cyclic GMP 
Addition  exp  content* 
% 
Serotonin, 10 #M  4  +263 •  60 
Carbamylcholine, 10 nM  4  +61  •  23 
Ascorbic acid, 5 mM  8  + 1636 •  203 
Cells were incubated for 5 min with or without additions 
as indicated. Data from 14 different cell preparations are 
represented.  In  these the  mean basal content of cyclic 
GMP was 2.1  •  0.1 pmol/10  ~ cells (mean •  SE). 
* Mean  •  SE  of  percentage  changes  caused  by  the 
addition in the indicated number of experiments. 
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FIGURE  1  Effect  of  ascorbic  acid  on  cyclic  GMP 
(cGMP) content of mononuclear cells.  Cells were incu- 
bated with or without ascorbic acid for 5 min at 37~ 
Data (means of duplicate incubations) from two different 
experiments (O, O) are presented. 
accumulation  of cyclic GMP,  whereas bradykinin 
and  histamine  did  not  enhance  chemotaxis  or 
increase cyclic GMP.  Only with concentrations of 
serotonin  >  10 #M  was there a  lack of correlation 
between  increased  cyclic  GMP  and  enhanced 
chemotaxis. Maximal effects of serotonin on cyclic 
GMP  in monocytes were produced with concentra- 
tions  of  50  100  uM,  but  effects  on  chemotaxis 
were  maximal  with  10 u,M  serotonin,  and  higher 
concentrations  failed  to  stimulate  and  even  de- 
creased  celt  movement.  This  phenomenon  has 
previously  been  seen  in  PMN  in  the  presence  of 
the  calcium  ionophore A23187  which  in  low con- 
centrations  enhances  chemotaxis  and  in  higher 
concentrations  is  inhibitory  (I).  Recently.  Clark 
et  al.  have  shown  that  histamine,  too,  has  a  bi- 
phasic  effect  on  eosinophil  chemotaxis  (4).  It  is 
conceivable that the inhibitory effect of high con- 
centrations of these agents is exerted at steps sub- 
sequent to the accumulation of cyclic nucleotides. 
In PMN,  on the other hand, although serotonin 
and,  as  previously  reported  (10),  ascorbic  acid 
increased  chemotaxis,  they  did  not  demonstrably 
alter  cyclic  GMP.  The  failure  to  demonstrate 
increases  in  the cyclic GMP  content  of PMN  on 
exposure  to  ascorbic acid  or  serotonin  in concen- 
trations  that  stimulated  chemotaxis  is  not,  of 
course,  inconsistent  with  the  suggestion  of  Es- 
tensen  et  al.  (7)  that  elevation  of  intracellular 
cyclic  GMP  enhances  cell  movement.  It  may  be 
that  changes  in  cyclic  GMP  too  small  to  be 
detected  in  our  assay  are  sufficient  to  influence 
PMN  function.  Alternatively, cyclic  GMP  eleva- 
tion  may  not  be  a  prerequisite  for  enhanced  cell 
movement,  and  agents  as  divergent  as  serotonin, 
carbamylcholine, and ascorbic acid  may influence 
chemotaxis through  other as  yet  undefined mech- 
anisms. 
SUMMARY 
Serotonin,  ascorbic  acid,  and  carbamylcholine 
enhanced  the  chemotactic  responsiveness  of 
human  monocytes  to  endotoxin-treated  serum. 
These  agents  caused  significant  accumulation  of 
cyclic  GMP  in  monocytes.  PMN  leukocyte 
chemotaxis  was  also  enhanced  by  these  agents 
although significant increases in cyclic GMP  were 
not demonstrated. 
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